Home › NDC Lookup › RxCUI directory › RxCUI 799835

Alvimopan 12 MG Oral Capsule — RxCUI 799835

RxNorm drug concept · Semantic clinical drug
RxCUI 799835 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI799835
Official nameAlvimopan 12 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alvimopan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps your digestive system wake up faster after certain bowel surgeries where part of the bowel is removed and reconnected. It's meant to shorten the time to gut recovery.
  • You'll get it in the hospital only. You get one capsule before surgery, then twice a day after surgery until you go home, for no more than 7 days and 15 doses. You can take it with...
  • In a 12-month study of people on long-term opioids, more heart attacks were seen with alvimopan. A cause hasn't been proven, and short-term use hasn't shown this. Still, it's restr...
  • The most common one in trials was indigestion. Let your nurse know about belly pain, cramping, diarrhea, nausea or vomiting, and report chest pain right away.
📖 Read our full Alvimopan guide →

🕸️ Concept Web — How Alvimopan 12 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Alvimopan 12 MG Oral Capsule RxCUI 799835

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Alvimopan 480639
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Entereg 482748
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alvimopan Oral Capsule 799834
    • Alvimopan Oral Product 1157133
    • Alvimopan Pill 1157134
    • Alvimopan Oral Capsule [Entereg] 801730
    • Entereg Oral Product 1166441
    • Entereg Pill 1166442
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Alvimopan 12 MG 799833
    • Alvimopan 12 MG Oral Capsule [Entereg] 801731
    • Alvimopan 12 MG [Entereg] 801729

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Alvimopan 12 MG SCDC · 799833
  • Alvimopan Oral Capsule SCDF · 799834
  • Alvimopan Oral Product SCDG · 1157133
  • Alvimopan Pill SCDG · 1157134

Brand-Name Concepts

  • Alvimopan 12 MG Oral Capsule [Entereg] SBD · 801731
  • Alvimopan 12 MG [Entereg] SBDC · 801729
  • Alvimopan Oral Capsule [Entereg] SBDF · 801730
  • Entereg Oral Product SBDG · 1166441
  • Entereg Pill SBDG · 1166442
  • Entereg BN · 482748

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 799835 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0668-82 6 BLISTER PACK in 1 CARTON (0054-0668-82) / 5 CAPSULE in 1... Alvimopan Hikma Pharmaceuticals USA Inc. 2024-02-06
00254-3012-55 6 BLISTER PACK in 1 CARTON (0254-3012-55) / 5 CAPSULE in 1... ALVIMOPAN Par Health USA, LLC 2023-05-03
00591-2312-15 30 BLISTER PACK in 1 CARTON (0591-2312-15) / 1 CAPSULE in 1... Alvimopan Actavis Pharma, Inc. 2020-12-01
51407-0870-33 5 BLISTER PACK in 1 CARTON (51407-870-33) / 6 CAPSULE in 1... Alvimopan Golden State Medical Supply, Inc. 2024-01-12
Observed labelers: Actavis Pharma, Inc. (1) · Golden State Medical Supply, Inc. (1) · Hikma Pharmaceuticals USA Inc. (1) · Par Health USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.